Skip to content

Cobra Biologics and Pharmaceutical Services

Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.

DNA
Viruses
Protein
Microbiota
Fill Finish

Latest News

View all

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford to ensure broad and equitable supply of the vaccine throughout the world, at no profit during the COVID-19 pandemic.

Find Out More

Cognate BioServices Completes Acquisition of Cobra Biologics

With the addition of Cobra's specialized expertise in plasmid DNA, viral vectors, protein and microbiota, from development to fill-finish, Cognate is well-positioned as a global industry-leading services provider to deliver drug development and manufacturing solutions to the cell and gene immunotherapy and regenerative medicine industry around the world.

Find Out More

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

Find Out More

Get In Touch

Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden.

Contact Us

About Cobra Biologics

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.

2 GMP approved facilities
320+ products released for clinical trials
20 Countries serviced

@CobraBiologics

8 hours ago

“This is a further milestone in the progression of the CGO1 project and it gives me great pride in Cobra playing su… https://t.co/mdc9pY7XFe

22 hours ago

Cobra Biologics delivers final plasmids for production of CG01 in CombiGene’s epilepsy project https://t.co/t3txm4bl90

22 hours ago

Cobra Biologics levererar de återstående plasmiderna för produktion av CG01 i CombiGenes epilepsi projekt https://t.co/7uxef8OQyG

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.